S0137 Didanosine, 25 milligrams
Also known as: ddI, didanosine, NRTI
Didanosine oral medication at 25 milligrams, a nucleoside reverse transcriptase inhibitor.
In Plain Language
HIV treatment; AIDS medication; antiviral for HIV
Clinical Context
Previously used for HIV infection. Largely replaced by newer antiretroviral agents with better tolerability and efficacy.
RVU Information
CPT S0137 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
S-codes are used by private payers (not Medicare) for services without a standard CPT or HCPCS code. Coverage varies significantly between insurers. Verify payer acceptance before billing and document medical necessity thoroughly.
Specialties
Frequently Asked Questions
What is CPT code S0137?
CPT S0137 (Didanosine, 25 milligrams) is a S Codes code. Didanosine oral medication at 25 milligrams, a nucleoside reverse transcriptase inhibitor.
Is S0137 covered by insurance?
S0137 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Previously used for HIV infection. Largely replaced by newer antiretroviral agents with better tolerability and efficacy.
When is CPT S0137 used?
Previously used for HIV infection. Largely replaced by newer antiretroviral agents with better tolerability and efficacy.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.